Previous 10 | Next 10 |
Preliminary data from a Phase 2 clinical trial evaluating NuCana's (NASDAQ: NCNA ) Acelarin (NUC-1031) in heavily pretreated patients with platinum-resistant ovarian cancer showed a treatment effect. More news on: NuCana plc, Healthcare stocks news, Stocks on the move, Read more ....
NuCana (NASDAQ: NCNA ): Q4 GAAP EPS of -£0.24 misses by £0.08 . More news on: NuCana plc, Earnings news and commentary, Healthcare stocks news, , Read more ...
First Patients Dosed in Global Phase III Biliary Tract Cancer Study (NuTide:121) with Potential for Accelerated Approval Filing Numerous Clinical Data Announcements Expected in 2020 Cash and Cash Equivalents to Fund Operations into the Second Half of 2021 EDINBUR...
EDINBURGH, United Kingdom, Feb. 25, 2020 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Cowen and Company 40 th Annual Health Care Conference...
Global NuTide:121 Study Is Enrolling up to 828 Patients and Comparing Acelarin plus Cisplatin to Gemcitabine plus Cisplatin NuTide:121 Trials-in-Progress Poster Presented at ASCO-GI SAN FRANCISCO, Jan. 27, 2020 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that the first...
Note: This stock was recommended for a 'watch item' position exclusively to Biotech Forum members one month ago when the stock traded at approximately $5.50 a share. We often miss opportunity because it's dressed in overalls and looks like work ”― Thomas A. Edison Today,...
Gainers: Protagonist Therapeutics (NASDAQ: PTGX ) +63% . More news on: Protagonist Therapeutics, Inc., Arbutus Biopharma Corporation, Kodiak Sciences Inc., Stocks on the move, Read more ...
EDINBURGH, United Kingdom, Nov. 26, 2019 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Don Munoz, Chief Financial Officer, will host one-on-one meetings at the Piper Jaffray 31st Annual Healthcare Conference in New York, NY on December 3 rd and 4 th , 2019. Event: Pi...
The following slide deck was published by NuCana plc in conjunction with this Read more ...
EDINBURGH, United Kingdom, Nov. 14, 2019 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Jefferies 2019 London Healthcare Conference in London, UK...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Jefferies Global Healthcare Conference. Event: Jefferies Global Healthca...
EDINBURGH, United Kingdom, May 21, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present at TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA. Ev...
Key Data Readouts on Track for All Programs in 2024 Randomized Phase 2 Study of 182 Second-Line Colorectal Cancer Patients Fully Enrolled NUC-7738 plus Pembrolizumab Demonstrated Encouraging Anti-Cancer Activity in Several Patients who were Resistant to PD-1 Inhibitors ...